150 related articles for article (PubMed ID: 33879633)
1. ITPKA induces cell senescence, inhibits ovarian cancer tumorigenesis and can be downregulated by miR-203.
Shaosheng W; Shaochuang W; Lichun F; Na X; Xiaohong Z
Aging (Albany NY); 2021 Apr; 13(8):11822-11832. PubMed ID: 33879633
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
3. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
4. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
Liao Y; Deng Y; Liu J; Ye Z; You Z; Yao S; He S
Gynecol Oncol; 2016 Dec; 143(3):655-663. PubMed ID: 27726922
[TBL] [Abstract][Full Text] [Related]
5. Circ_0007841 accelerates ovarian cancer development through facilitating MEX3C expression by restraining miR-151-3p activity.
Huang K; Liu D; Su C
Aging (Albany NY); 2021 Apr; 13(8):12058-12066. PubMed ID: 33896797
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
[TBL] [Abstract][Full Text] [Related]
7. ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.
Wang YW; Ma X; Zhang YA; Wang MJ; Yatabe Y; Lam S; Girard L; Chen JY; Gazdar AF
J Thorac Oncol; 2016 Sep; 11(9):1469-81. PubMed ID: 27234602
[TBL] [Abstract][Full Text] [Related]
8. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3.
Li GC; Qin XL; Song HH; Li YN; Qiu YY; Cui SC; Wang YS; Wang H; Gong JL
J Cell Physiol; 2019 Dec; 234(12):22331-22342. PubMed ID: 31140597
[TBL] [Abstract][Full Text] [Related]
9. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
[TBL] [Abstract][Full Text] [Related]
10. MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway.
Xiaohong Z; Lichun F; Na X; Kejian Z; Xiaolan X; Shaosheng W
Tumour Biol; 2016 Nov; 37(11):14989-14997. PubMed ID: 27655286
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells.
Shao Y; Liu X; Meng J; Zhang X; Ma Z; Yang G
Mol Ther; 2019 Sep; 27(9):1653-1664. PubMed ID: 31278033
[TBL] [Abstract][Full Text] [Related]
12. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1.
Wen Z; Zhao S; Liu S; Liu Y; Li X; Li S
Mol Med Rep; 2015 Sep; 12(3):3775-3780. PubMed ID: 26004261
[TBL] [Abstract][Full Text] [Related]
14. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
[TBL] [Abstract][Full Text] [Related]
15. MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
Liu R; Liu F; Li L; Sun M; Chen K
Biomed Pharmacother; 2015 May; 72():52-7. PubMed ID: 26054675
[TBL] [Abstract][Full Text] [Related]
16. miR-22 represses cancer progression by inducing cellular senescence.
Xu D; Takeshita F; Hino Y; Fukunaga S; Kudo Y; Tamaki A; Matsunaga J; Takahashi RU; Takata T; Shimamoto A; Ochiya T; Tahara H
J Cell Biol; 2011 Apr; 193(2):409-24. PubMed ID: 21502362
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.
Yang H; Qi Y; Wang XL; Gu JJ; Shi TM
Mol Cell Biochem; 2020 Apr; 467(1-2):95-105. PubMed ID: 32095930
[TBL] [Abstract][Full Text] [Related]
18. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
19. CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.
Wang LL; Zong ZH; Liu Y; Guan X; Chen S; Zhao Y
J Cell Mol Med; 2019 Dec; 23(12):8472-8481. PubMed ID: 31639291
[TBL] [Abstract][Full Text] [Related]
20. Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.
Wang Z; Gao J; Zhou J; Liu H; Xu C
J Gynecol Oncol; 2019 Mar; 30(2):e26. PubMed ID: 30740957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
